Pulmonx Corp.
NASDAQ: LUNGSan Jose, US · Delaware corporation · 4 known investors
Pulmonx develops the Zephyr Valve, a bronchoscopic medical device for treating severe COPD and emphysema without surgery. The device targets patients with severe lung disease requiring minimally invasive intervention.
Founders & leadership
GE
GLENDON E. FRENCHExecutive Officer, Director
DG
DANA G. MEAD, JRDirector
SS
STEPHEN SALMONDirector
RP
RODNEY PERKINS, M.D.Director
OS
OERN STUGEDirector
MM
MICHAEL MATLYDirector
LC
LAUREN CRISTINAExecutive Officer
RF
RICH FERRARIDirector
SL
STAFFAN LINDSTRANDDirector
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$65.1MraisedApr 2019 · 18 investors · OtherRule 506(b)
▶$65.1MraisedApr 2019 · 18 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- STAFFAN LINDSTRANDDirector
- LAUREN CRISTINAExecutive Officer
- GLENDON E. FRENCHExecutive Officer, Director
- RICH FERRARIDirector
- MICHAEL MATLYDirector
- STEPHEN SALMONDirector
- DANA G. MEAD, JRDirector
- CHARLES CHONDirector
- OERN STUGEDirector
- RODNEY PERKINS, M.D.Director
- Offering amount
- $65.1M
- Amount sold
- $65.1M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50MraisedApr 2017 · 1 investors · OtherRule 506(b)
▶$50MraisedApr 2017 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- GLENDON E. FRENCHExecutive Officer, Director
- DANA G. MEAD, JRDirector
- STEPHEN SALMONDirector
- RODNEY PERKINS, M.D.Director
- OERN STUGEDirector
- MICHAEL MATLYDirector
- LAUREN CRISTINAExecutive Officer
- STAFFAN LINDSTRANDDirector
- RICH FERRARIDirector
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Brokerages Set Pulmonx Corporation (NASDAQ:LUNG) PT at $5.58 - Defense Worlddefenseworld.net · 2026
- Pulmonx to Release Q2 2026 Financial Results July 29 | LUNG Stock Newsstocktitan.net · 2026
- Pulmonx Corporation Raises $66.0M | Signalbasetrysignalbase.com · 2026
- Pulmonx, Inc. Raises $32 Million for Launch of Emphysema Products - BioSpacebiospace.com · 2010
- Pulmonx News - Pulmonx Raises $32 Million for Launch of Emphysema Productspulmonx.com